Stenocare A/S (CPH:STENO)
Denmark · Delayed Price · Currency is DKK 0.9000
+0.0020 (0.22%)
Sep 11, 2026, 12:17 PM CET
Stenocare Market Cap
Stenocare has a market cap or net worth of 38.79 million as of September 10, 2026. Its market cap has decreased by -17.43% in one year.
Market Cap
38.79M
Enterprise Value
38.10M
Revenue
11.52M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.90
ChartMarket Cap Chart
Since May 18, 2020, Stenocare's market cap has decreased from 326.86M to 38.79M, a decrease of -88.13%. That is a compound annual growth rate of -28.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2026 | 41.64M | -34.86% |
| Dec 30, 2025 | 63.93M | 146.13% |
| Dec 30, 2024 | 25.97M | -43.63% |
| Dec 29, 2023 | 46.08M | -56.10% |
| Dec 30, 2022 | 104.96M | -11.04% |
| Dec 30, 2021 | 117.98M | -47.32% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| May 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.27T |
| Genmab | 124.47B |
| Coloplast | 97.45B |
| Demant | 60.87B |
| Gubra | 5.25B |
| BioPorto | 589.18M |
| ViroGates | 101.17M |
| Pharma Equity Group | 100.90M |